美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

2倍做多NVO ETF-Defiance

16.04

+1.097.29%

盤後：16.01-0.0300-0.19%18:30 EDT

成交量：33.65萬

成交額：527.63萬

市值：4,151.31萬

市盈率：- -

高：16.04

開：15.50

低：15.36

收：14.95

52周最高：36.00

52周最低：9.23

股本：258.81萬

流通股本：258.81萬

量比：0.88

換手率：13.00%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

諾和諾德(NVO)股票8月25日收盤上漲3.71%：背後推手曝光

TradingKey中文

隨着醫療保健成本的上升，2027年將有更多美國僱主停止提供減肥藥物

大行評級｜小摩：上調諾和諾德目標價至275丹麥克朗，維持「中性」評級

諾和諾德上半年營收增長司美格魯肽成收入支柱

经济参考网

摩根大通上調目標價與銷售預期，諾和諾德股價走高

南方兩倍做多三星電子跌超18%，南方兩倍做多SK海力士跌超5%。

焦點-打鼾、地鐵和隱形廣告：大型製藥公司如何瞄準中國人的腰圍

三星跌近8%，港股存儲芯片股全線下跌，兩倍做多三星電子大跌16%

韓國上半年查獲非法進口減重藥物為去年全年三倍

韓國上半年查獲非法進口減重藥物為去年全年三倍

环球市场播报

韓國上半年查獲非法進口減重藥物為去年全年三倍

據報諾和諾德（NVO）啓動低劑量減肥藥試驗

Novo啓動研究，旨在確定Wegovy口服藥的最低有效劑量

諾和諾德(NVO.US)啓動低劑量Wegovy口服藥臨床研究瞄準更廣泛減重人群

大型藥企全力研發無嚴重副作用的減重藥物

據媒體消息，諾和諾德(NVO.US)在一項新的肥胖症研究中，開始測試低劑量Wegovy口服藥片。

大型藥企全力研發無嚴重副作用的減重藥物

环球市场播报

美股異動｜減肥藥概念股逆勢上揚，禮來漲2.6%

ETF日報 | 2倍做多AXT ETF升逾35%；2倍做多Cerebras ETF升逾30%；三倍做多半導體ETF漲近5%；半導體槓桿領升

步長製藥：控股子公司藥品臨床試驗申請獲受理，研發投入約3175.45萬元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/NVOX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NVOX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOX\",,,,,undefined,":{"symbol":"NVOX","market":"US","secType":"STK","nameCN":"2倍做多NVO ETF-Defiance","latestPrice":16.04,"timestamp":1787688000000,"preClose":14.95,"halted":0,"volume":336521,"hourTrading":{"tag":"盘后","latestPrice":16.01,"preClose":16.04,"latestTime":"18:30 EDT","volume":1399,"amount":22477.980623000003,"timestamp":1787697000019,"change":-0.03,"changeRate":-0.00187,"amplitude":0.009882},"delay":0,"changeRate":0.07290969899665552,"floatShares":2588101,"shares":2588101,"eps":0,"marketStatus":"盤後交易","change":1.09,"latestTime":"08-25 19:07:35 EDT","open":15.5,"high":16.04,"low":15.355,"amount":5276251.848699001,"amplitude":0.045819,"askPrice":16.02,"askSize":49,"bidPrice":15.9,"bidSize":5,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":14.95,"sharesOutstanding":4098101,"nav":14.83,"aum":38381537.83,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":15.4,"preClose":14.95,"latestTime":"08:58 EDT","volume":539,"amount":8293.227558,"timestamp":1787662714608,"change":0.45,"changeRate":0.0301,"amplitude":0.007358},"postHourTrading":{"tag":"盘后","latestPrice":16.01,"preClose":16.04,"latestTime":"18:30 EDT","volume":1399,"amount":22477.980623000003,"timestamp":1787697000019,"change":-0.03,"changeRate":-0.00187,"amplitude":0.009882},"volumeRatio":0.878147,"impliedVol":0.6386,"impliedVolPercentile":0.108},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOX\",,,,,undefined,":{"symbol":"NVOX","floatShares":2588101,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.878147,"shares":2588101,"dividePrice":0,"high":16.04,"amplitude":0.045819,"preClose":14.95,"low":15.355,"week52Low":9.23,"pbRate":"--","week52High":36,"institutionHeld":0,"latestPrice":16.04,"committee":-0.814815,"eps":0,"divideRate":0,"volume":336521,"delay":0,"ttmEps":0,"open":15.5,"prevYearClose":21.89,"prevWeekClose":14.83,"prevMonthClose":15.035,"prevQuarterClose":16.05,"fiveDayClose":14.205,"twentyDayClose":17.79,"sixtyDayClose":14.95},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-09","symbol":"NVOX","defaultRemindTime":1765290600000,"type":"split","dateTimestamp":1765256400000,"forFactor":8,"toFactor":1,"ratio":8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662752662","title":"諾和諾德(NVO)股票8月25日收盤上漲3.71%：背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752662","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662752662?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 04:16","pubTimestamp":1787688980,"startTime":"0","endTime":"0","summary":"• 华尔街上调诺和诺德目标价及长期财务预测。\n• GLP-1 疗法的强劲普及与股票回购提振了市场信心。\n• 该公司公布年度营收为 467.0 亿美元，净利润为 154.8 亿美元。","market":"other","thumbnail":"https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262131303-market-movers-nvo-20260825","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU0154236417.USD","IE00BKVL7J92.USD","LU1093756168.USD","BK4007","PPH","LU1093756325.SGD","NVOX","THNR","NVOC","BK4585","BK4532","NVOH","NVO","BK4599","BK4588","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662073007","title":"隨着醫療保健成本的上升，2027年將有更多美國僱主停止提供減肥藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2662073007","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662073007?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 22:00","pubTimestamp":1787666442,"startTime":"0","endTime":"0","summary":"随着医疗保健成本的上升，2027年将有更多美国雇主停止提供减肥药物Amina Niasse路透纽约8月25日-据“健康商业集团”周二发布的一项调查显示，鉴于企业面临医疗成本不断攀升的压力，美国约14%的雇主已决定或计划在2027年停止报销GLP-1类药物。该组织表示，如果雇主在2027年不采取措施控制成本，医疗保健成本预计将增长9.2%，高于2026年的8.5%。药房费用占雇主医疗保健支出的25%，预计2027年将增长12%，与前一年持平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL4T44M0YY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","LU2237443549.SGD","LU0672654240.SGD","LU0708995401.HKD","LU2106854487.HKD","LU0456855351.SGD","LU1267930730.SGD","LU1917777945.USD","LU0320765059.SGD","LU2271345857.HKD","LU0345770993.USD","SG9999015945.SGD","LU0174119429.USD","LU0058720904.USD","LU2361045086.USD","LU2461242641.AUD","IE00BJT1NW94.SGD","BK4533","LU0471298777.SGD","LU0154236417.USD","ELIS","IE00B1XK9C88.USD","FHLC","LU0823434583.USD","LU1366192091.USD","LU1814569148.SGD","SG9999014880.SGD","LU1551013425.SGD","LU2236285917.USD","LU0417517546.SGD","HRTS","IE0002141913.USD","SGXZ99366536.SGD","IE0005OL40V9.USD","RXL","IE00BJLML261.HKD","IE00BZ1G4Q59.USD","LU0106261372.USD","BK4516","LU0266013472.USD","LU2087625088.SGD","LU2361044949.HKD","LU2491050071.SGD","LU2746668974.SGD","LU0964807845.USD","LU2456880835.USD","MEDX","LU0466842654.USD","LU1629891620.HKD","ELIL","LU1093756168.USD","PPH","LU2417539215.USD","LU2168564149.EUR","LLY","THNR","LU2746668461.USD","WDNA","LU2462157665.USD","LU0320765992.SGD","LU0097036916.USD","BK4588","IE00B7KXQ091.USD","LU0158827781.USD","LU1623119135.USD","LU1720051108.HKD","IE00BK4W5L77.USD","IE00BKVL7J92.USD","LU2491050154.USD","LU2602419157.SGD","AGNG","SG9999018857.SGD","LU0203202063.USD","LU2168563687.JPY","SG9999015952.SGD","LU0061475181.USD","LU1064131342.USD","LU1720051017.SGD","LU0114720955.EUR","LU2023250330.USD","LU2357305700.SGD","IE0009355771.USD","LU1035775433.USD","LU1548497426.USD","LU2168564065.EUR","LU0882574055.USD","SG9999001176.USD","LU1023059063.AUD","LU2756315318.SGD","OZEM","LU1323610961.USD","LU0109394709.USD","LU2089984988.USD","LU2552382215.SGD","LLII","LU1551013342.USD","LU2237438978.USD","MEDI","SG9999015986.USD","IE0001KFT4U8.USD","LU2237443465.HKD","LU2360106947.USD","IE00B4JS1V06.HKD","IE00BKDWB100.SGD","LLYX","LU0353189763.USD","IYH","LU0640476718.USD","LU0354030511.USD","LU2112291526.USD","LU2756315664.SGD","SG9999017495.SGD","IXJ","LU0889565916.HKD","LU1232071149.USD","LU2089283258.USD","LU2896262040.SGD","LU0256863811.USD","LU0943347566.SGD","LU1280957306.USD","NVO","LU0094547139.USD","LU0471298694.HKD","LLYZ","IE00BWXC8680.SGD","SG9999018865.SGD","IE0004445015.USD","LU0096364046.USD","IE00B775H168.HKD","BK4585","LU0689472784.USD","LU1979441026.SGD","LU2028103732.USD","SGXZ51526630.SGD","XLV","LU0225283273.USD","LU2361044865.SGD","NVOC","LU2750360641.GBP","JDOC","SG9999001176.SGD","SGXZ57979304.SGD","LU1989771016.USD","IE00BFSS7M15.SGD","LU1691799644.USD","LU2552382058.USD","LU2089284900.SGD","IE00BN29S564.USD","LU0683600562.USD","LU0122379950.USD","LU2471134523.USD","LU1868837300.USD","LU2023250504.SGD","LU2491049909.HKD","LU1145028129.USD","NVOX","LU0820561818.USD","LU2237443622.USD","LU2468319806.SGD","LU2237443895.HKD","LU0256863902.USD","LU0234572021.USD","BK4599","LU1868836757.USD","SG9999013999.USD","LU0882574139.USD","LU1974910355.USD","IE00BKPKM429.USD","IE00BFTCPJ56.SGD","IE0004445239.USD","LU0432979614.USD","LU0823434740.USD","LU1057294990.SGD","GB00BDT5M118.USD","LU1712237335.SGD","LU1983299246.USD","LU1988902786.USD","LU2471134879.HKD","LU2213496289.HKD","LU0354030438.USD","LU2265009873.SGD","TMED","LU1061106388.HKD","LU2471134796.USD","SG9999015978.USD","SGXZ81514606.USD","LU0133085943.USD","LU2237443382.USD","LU0006306889.USD","LU2324357040.USD","LU0385154629.USD","SG9999014898.SGD","CURE","LU0079474960.USD","LU1804176565.USD","LU0786609619.USD","IHE","SG9999014914.USD","BK4532","GDOC","BK4007","LU0820562030.AUD","LU1868836591.USD","LU1868837136.USD","LU2108987350.USD","LU0238689110.USD","LU2211815571.USD","IE00B2B36J28.USD","LU0109391861.USD","VHT","LU2063271972.USD","LU2111349929.HKD","LU0203201768.USD","LU2462591350.SGD","LU0198837287.USD","IE00BJJMRY28.SGD","IE00BJJMRZ35.SGD","LU0323591593.USD","SGXZ31699556.SGD","TRUH","LU0787776722.HKD","LU1127390331.HKD","LU0316494557.USD","LU2168564495.EUR","LU0345770308.USD","LU1069344957.HKD","LU2750360997.AUD","BK4534","PJP","LU1093756325.SGD","LU0289739699.SGD","IE00BJJMRX11.SGD","ILDR","LU2552382132.HKD","MHIP","IE00B4R5TH58.HKD","IE00BFSS8Q28.SGD","LU0353189680.USD","NVOH","FTXH","SG9999014906.USD","LU0158827948.USD","LU2471134952.CNY","LU2237443978.SGD","LU1291159041.SGD","LU2023251221.USD","IE00B1BXHZ80.USD","LU1868836914.USD","LU2264538146.SGD","LU0210536198.USD","LU2168564222.USD","IE00BK4W5M84.HKD","BK4581","LU0820561909.HKD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662737643","title":"大行評級｜小摩：上調諾和諾德目標價至275丹麥克朗，維持「中性」評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2662737643","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662737643?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 21:07","pubTimestamp":1787663263,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2237443382.USD","LU0496365809.HKD","IE00BFXG1179.USD","LU1267930490.SGD","LU2430703095.HKD","LU2237443549.SGD","LU0251132253.USD","LU0211331839.USD","IE00BK4W5L77.USD","LU1496350502.SGD","LU2023250843.SGD","LU2244417387.USD","BK4599","BK4550","LU0211327993.USD","FTXO","LU0868494708.USD","XLF","LU0787776722.HKD","LU2054465674.USD","LU0345770993.USD","UYG","LU0170899867.USD","LU0310799852.SGD","LU2756315318.SGD","NVOC","IE00B1BXHZ80.USD","LU0106261372.USD","LU2381873111.SGD","LU1064131342.USD","LU1668664300.SGD","IE0034235188.USD","LU1145028129.USD","LU1894683264.USD","VFH","JPO","IE00BKDWB100.SGD","LU1244550494.USD","LU0942090050.USD","LU0234572021.USD","LU1894683348.USD","LU2430703251.USD","NVO","LU2237443895.HKD","LU0971096721.USD","IXG","LU0256863811.USD","LU1116320737.USD","LU1551013425.SGD","LU1548497426.USD","IE00BHPRN162.USD","IE00BYXW3230.USD","LU0320765489.SGD","TRUF","THNR","IE00BLSP4239.USD","LU0417517546.SGD","BK4588","LU1280957306.USD","IE00B1XK9C88.USD","LU0048584097.USD","LU0203347892.USD","LU1093756325.SGD","IE00BBT3K403.USD","LU2023250504.SGD","LU1629891620.HKD","LU1670627923.USD","LU2357627491.SGD","LU2746668461.USD","LU0640476718.USD","LU0208291251.USD","IE000M9KFDE8.USD","LU0345770308.USD","LU0238689110.USD","LU0943347566.SGD","LU1084165304.USD","LU0345769128.USD","NVOH","LU1261432733.SGD","LU1244550577.SGD","LU1720051108.HKD","LU0211326755.USD","LU0320765646.SGD","LU2456880835.USD","LU1670628061.USD","LU0234570918.USD","IE00BJTD4V19.USD","LU1363072403.SGD","LU0211326839.USD","LU2264538146.SGD","LU2236285917.USD","BK4516","IYG","IE00BJLML261.HKD","LU1116320901.HKD","LU0187121727.USD","LU1551013342.USD","LU0265550359.USD","LU2552382215.SGD","LU0149725797.USD","LU0256863902.USD","LU0868494617.USD","IE00BKVL7J92.USD","LU1093756168.USD","LU2211815571.USD","LU2505996681.GBP","LU1720051017.SGD","LU0683600562.USD","LU0323591593.USD","LU2552382132.HKD","OZEM","LU0964807845.USD","LU2430703178.SGD","LU2237443622.USD","IE0034235303.USD","BK4207","LU0215105999.USD","LU2592432038.USD","LU0154236417.USD","LU2237443978.SGD","LU0820561909.HKD","LU1974910355.USD","BK4581","IYF","LU0976567544.SGD","BK4585","IE0034235295.USD","LU1366192091.USD","LU2023250330.USD","IE00BWXC8680.SGD","LU0203345920.USD","LU1917777945.USD","IE00B775SV38.USD","LU1162221912.USD","BK4504","LU2106854487.HKD","LU2357305700.SGD","IE00BDRTCR15.USD","LU2756315664.SGD","IE00BZ1G4Q59.USD","NVOX","TFNS","LU2552382058.USD","LU0070302665.USD","LU1988902786.USD","LU0859254822.USD","BK4532","JPM","IE00BLSP4452.SGD","LU1244550221.USD","KBWB","LU0345769631.USD","LU0211328371.USD","LU0265550946.USD","LU1032466523.USD","SG9999002232.USD","LU0006306889.USD","LU0820561818.USD","LU2237443465.HKD","FNCL","LU1119994496.HKD","SG9999002224.SGD","LU0882574139.USD","LU2213496289.HKD","LU1496350171.SGD","BK4007","BK4533","LU2417539215.USD","BK4566","IE00B3S45H60.SGD","IE00BN8TJ469.HKD","LU2505996509.AUD","LU0267386448.USD","LU2746668974.SGD","LU0689472784.USD","JPMO","LU1914381329.SGD","IE00BJTD4N35.SGD","LU0820562030.AUD","LU0106831901.USD","BK4534","LU2462157665.USD","IE00BDCRKT87.USD","IE00BK4W5M84.HKD","LU2242649171.HKD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662773743","title":"諾和諾德上半年營收增長 司美格魯肽成收入支柱","url":"https://stock-news.laohu8.com/highlight/detail?id=2662773743","media":"经济参考网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662773743?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 20:57","pubTimestamp":1787662627,"startTime":"0","endTime":"0","summary":"丹麦制药巨头诺和诺德（NovoNordisk，NYSE：NVO）近日公布了2026年第二季度及上半年部分关键财务指标。财报显示，今年上半年，诺和诺德实现总营收1753.11亿丹麦克朗（约273.8亿美元），按固定汇率计算同比增长13%；实现归属于母公司股东的净利润695.46亿丹麦克朗（约108.6亿美元），同比增长25.22%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608253853266681.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608253853266681.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4599","NVOC","THNR","OZEM","IE00BZ1G4Q59.USD","BK4588","LU0154236417.USD","BK4007","LU1093756168.USD","NVO","NVOX","NVOH","IE00BKVL7J92.USD","PPH","BK4532","LU1093756325.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662816247","title":"摩根大通上調目標價與銷售預期，諾和諾德股價走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2662816247","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662816247?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 15:12","pubTimestamp":1787641960,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["OZEM","BK4585","BK4007","NVOC","NVO","BK4532","THNR","PPH","LU1093756325.SGD","NVOH","IE00BKVL7J92.USD","LU0154236417.USD","BK4599","IE00BZ1G4Q59.USD","BK4588","LU1093756168.USD","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661822339","title":"南方兩倍做多三星電子跌超18%，南方兩倍做多SK海力士跌超5%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661822339","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661822339?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 13:41","pubTimestamp":1787550098,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ETNG","SAA","RGTC","SKHZ","NVTC","ONTX","SPYQ","YSPY","VRC","RAM","LITX","EDZ","SKHYV","SMAX","SPDN","COZX","NVOC","SKHA","SPY","XW","RGYY","SKDD","VRTL","SH","SPUU","EEMO","RGTZ","SPXU","SPXS","TEUP","SKUU","SIMX","SKHU","SKHX","HYNX","ALA","OSSL","DRAL","MVV","UPRO","MMAX","SPYU","SDS","SKHY","LITC","NBIC","NVOX","LITU","IVV","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661228461","title":"焦點-打鼾、地鐵和隱形廣告：大型製藥公司如何瞄準中國人的腰圍","url":"https://stock-news.laohu8.com/highlight/detail?id=2661228461","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661228461?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 13:15","pubTimestamp":1787548554,"startTime":"0","endTime":"0","summary":"中国不允许制药公司直接向消费者宣传处方药。临床试验表明，礼来的GLP-1药物Mounjaro可缓解该病症。这家制药公司致力于使其公共传播中的语言更通俗易懂。医疗和法律专家指出，某些体重管理宣传活动也可能越界成为药物广告。礼来公司在声明中表示，其教育活动并未推广任何特定药品，且与中国的健康战略“保持一致”。辉瑞、创新药业、美团以及中国市场监管部门均拒绝或未回应置评请求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4S44L0C9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","MHIP","LU0354030511.USD","LU2097828557.USD","BK4550","LU0345770993.USD","LU0210536198.USD","LU0106261372.USD","HRTS","LU2471134796.USD","LU1969619763.USD","SG9999014914.USD","IE00BFSS8Q28.SGD","LU1061106388.HKD","LU2023251221.USD","LU1280957306.USD","BK1589","LU0306806265.USD","LU1814569148.SGD","LU0985481810.HKD","LU1093756325.SGD","LU2602419157.SGD","SG9999015978.USD","LU0238689110.USD","LU0943347566.SGD","NVOH","LU1720051108.HKD","LU2491050154.USD","LU2361045086.USD","LU2471134952.CNY","LU2264538146.SGD","LU0058720904.USD","IXJ","SG9999015952.SGD","LU2552382215.SGD","LU1023059063.AUD","LU0256863902.USD","IE00BFTCPJ56.SGD","LU0466842654.USD","LU2097828714.EUR","BK4568","LU0882574055.USD","LU2097828805.USD","LU2237443622.USD","IHE","LU2168564495.EUR","LU0820561909.HKD","BK4581","SGXZ99366536.SGD","LU1917777945.USD","LU2357305700.SGD","01801","SGXZ31699556.SGD","LU0109394709.USD","RXL","LU1868836757.USD","LU0094547139.USD","IE0005OL40V9.USD","LU2746668974.SGD","LU0689472784.USD","LU2097828631.EUR","IE00B19Z3581.USD","LU0432979614.USD","LU2491050071.SGD","IE00BK4W5M84.HKD","LU0316494557.USD","IE00BKPKM429.USD","LU2237443382.USD","LU0786609619.USD","GDOC","LU2750360997.AUD","LU1989771016.USD","LU2168564222.USD","BK1161","LU0133085943.USD","LU0787776722.HKD","LU0823416689.USD","LU0170899867.USD","LU2756315318.SGD","IE00B1BXHZ80.USD","LU0463099449.HKD","LU0326950275.SGD","IE00BKDWB100.SGD","LU1894683348.USD","LU2111349929.HKD","NVO","LU0708995401.HKD","CANC","GB00BDT5M118.USD","LU2237438978.USD","ELIS","LU0266013472.USD","LU0109391861.USD","IE0002270589.USD","FHLC","LU1629891620.HKD","LU0640476718.USD","LU2596442595.SGD","IE000M9KFDE8.USD","LU0158827781.USD","LU0345770308.USD","IE00BJJMRX11.SGD","LU2236285917.USD","SG9999014898.SGD","LU0868494617.USD","LU1093756168.USD","LU2211815571.USD","LU0456855351.SGD","ELIL","IE00B2B36J28.USD","LU0323591593.USD","LU2552382132.HKD","LU0502904849.HKD","TMED","HK0000165453.HKD","LU1868837136.USD","LU1974910355.USD","LU2361044865.SGD","LU2023250330.USD","LU2265009873.SGD","LU2106854487.HKD","SG9999013999.USD","SG9999001176.SGD","LU2471134879.HKD","LU2756315664.SGD","IE00BZ1G4Q59.USD","LU0158827948.USD","LU2552382058.USD","SGXZ51526630.SGD","SG9999017495.SGD","IE00BLSP4452.SGD","IE00BJJMRY28.SGD","LU0289739699.SGD","LU0006306889.USD","LU0820561818.USD","LU0061475181.USD","LU0882574139.USD","MEDI","IE0004445015.USD","LU2417539215.USD","LU2089284900.SGD","LU1232071149.USD","BK4534","LU2271345857.HKD","WDNA","LU2242644610.SGD","IE0001KFT4U8.USD","LU1323610961.USD","LU0823434740.USD","SG9999001176.USD","BK4599","LU2360106947.USD","IE00BN29S564.USD","NVOC","LU2089283258.USD","LU2168564149.EUR","LU0471298777.SGD","LU1894683264.USD","LU0306807586.USD","IE00BJJMRZ35.SGD","LU0114720955.EUR","IE00B4R5TH58.HKD","LU2237443895.HKD","LU1868836914.USD","LU1551013425.SGD","SG9999015986.USD","LLYZ","LU0122379950.USD","SG9999014906.USD","JDOC","LU0353189763.USD","BK4588","LU1188198961.HKD","BK1583","LU2746668461.USD","LU2023250504.SGD","LU0321505439.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU0244354667.USD","LU0354030438.USD","LU0225283273.USD","LU2087625088.SGD","LU0321505868.SGD","SG9999011175.SGD","LU0455707207.USD","IE0002141913.USD","LU2108987350.USD","LLII","AGNG","LU2468319806.SGD","IE00BJLML261.HKD","KURE","LU1551013342.USD","SG9999018865.SGD","SG9999018857.SGD","LU0353189680.USD","MEDX","LU0385154629.USD","LU1720051017.SGD","OZEM","LU0154236417.USD","LU2237443978.SGD","LU2896262040.SGD","LU1267930730.SGD","LU1691799644.USD","LU1366192091.USD","LU2097828474.EUR","LU0096364046.USD","SGXZ81514606.USD","NVOX","LU1979441026.SGD","LU1988902786.USD","SG9999015945.SGD","LU0672654240.SGD","LU1127390331.HKD","IE0004445239.USD","LLY","LU0203201768.USD","ILDR","LU2237443465.HKD","SG9999002224.SGD","LU2213496289.HKD","LU1983299246.USD","LLYX","LU2462591350.SGD","LU1069344957.HKD","LU2324357040.USD","LU2462157665.USD","LU0320765059.SGD","IE00BFSS7M15.SGD","LU0198837287.USD","LU2361044949.HKD","LU2237443549.SGD","IE00BK4W5L77.USD","LU0097036916.USD","LU1712237335.SGD","LU1868837300.USD","LU2491049909.HKD","IE00B3T34201.USD","LU0823434583.USD","LU1064131342.USD","LU1035775433.USD","LU2168563687.JPY","LU2461242641.AUD","IE00B7KXQ091.USD","LU1145028129.USD","LU0234572021.USD","LU2168564065.EUR","LU0225771236.USD","LU1804176565.USD","LU1066051498.USD","LU0256863811.USD","LU2488822045.USD","FTXH","IE0009355771.USD","LU1548497426.USD","THNR","IE00BLSP4239.USD","LU0417517546.SGD","IE00B1XK9C88.USD","CURE","IE00BBT3K403.USD","LU0225284248.USD","LU2089984988.USD","LU2471134523.USD","LU1883839398.USD","SG9999003800.SGD","BK4592","LU2456880835.USD","PFE","BK4516","LU0889565916.HKD","SG9999014880.SGD","IYH","LU0174119429.USD","PJP","LU2112291526.USD","IE00BKVL7J92.USD","VHT","LU0320765992.SGD","LU0683600562.USD","LU0964807845.USD","LU2028103732.USD","BK4585","LU0203202063.USD","LU2063271972.USD","SGXZ57979304.SGD","IE00BWXC8680.SGD","LU1623119135.USD","IE00B4JS1V06.HKD","BK4532","LU2750360641.GBP","SG9999002232.USD","XLV","IE00B775H168.HKD","BK4007","BK4533","LU1868836591.USD","IE00B19Z3B42.SGD","LU0079474960.USD","LU0820562030.AUD","LU1291159041.SGD","LU2328871848.SGD","TRUH","PPH","LU0471298694.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661247613","title":"三星跌近8%，港股存儲芯片股全線下跌，兩倍做多三星電子大跌16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661247613","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661247613?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 10:52","pubTimestamp":1787539920,"startTime":"0","endTime":"0","summary":"8月24日消息，港股存储芯片股集体下跌，其中，南方两倍做多三星电子大跌16%，兆易创新、伟仕佳杰跌超5%，澜起科技跌超4%，南方东英SK海力士每日杠杆最多 产品跌超3%。其中，三星电子跌近8%，SK海力士一度跌超3%。三星上周五表示，今年的股东回报规模将在90万亿至110万亿韩元之间，其中包括第三季度派发30万亿韩元现金股息。KB证券此前预测三星电子用于股东回报的资金可能高达200万亿韩元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2026-08-24/doc-inipkriw2061760.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LITZ","VRTL","SPYQ","NEBX","MUG","RGTU","SPDN","SAA","ONTX","TEUP","RAM","07747","RAMZ","HBMX","RGTC","SPXU","DRMP","NBIL","OSSL","FTXL","KCAI","NVTC","COZX","SPUU","SSNLF","MUU","VRC","ETNG","LITC","VXUS","VOO","DRAM","MVV","07347","NBIC","ALA","MUD","SH","NVOX","DRMY","DISK","NVTX","NVOH","SIMX","XW","09747","RGTX","SMAX","EMXC","HIBL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661421362","title":"韓國上半年查獲非法進口減重藥物為去年全年三倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2661421362","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661421362?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 10:04","pubTimestamp":1787537094,"startTime":"0","endTime":"0","summary":"来源：环球市场播报韩国海关周一公布的数据显示，上半年从境外非法进口Wegovy、Mounjaro等减重药物的查获案件数量是2025年全年查获量的三倍以上。韩国关税厅统计数据显示，16月，海关共查获4155起通过海淘直购及其他非法渠道走私Wegovy、Mounjaro的案件，远高于2025年全年的1189起。非法进口大多通过国际邮件渠道：越来越多韩国民众从海外线上商城购买这类减重药物，再通过国际快递寄回国内。另有656起案件为旅客个人携带入境，高于去年全年的134起。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2026/08/24100458213801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["NVOC","OZEM","NVOH","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661504242","title":"韓國上半年查獲非法進口減重藥物為去年全年三倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2661504242","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661504242?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 10:01","pubTimestamp":1787536889,"startTime":"0","endTime":"0","summary":"韩国海关周一公布的数据显示，上半年从境外非法进口Wegovy、Mounjaro等减重药物的查获案件数量是2025年全年查获量的三倍以上。　　韩国关税厅统计数据显示，16月，海关共查获4155起通过海淘直购及其他非法渠道走私Wegovy、Mounjaro的案件，远高于2025年全年的1189起。　　非法进口大多通过国际邮件渠道：越来越多韩国民众从海外线上商城购买这类减重药物，再通过国际快递寄回国内。　　韩国禁止旅客随身携带Wegovy与Mounjaro入境。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-24/doc-inipkrka2981063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["NVOX","NVOC","OZEM","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661242360","title":"韓國上半年查獲非法進口減重藥物為去年全年三倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2661242360","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661242360?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 09:59","pubTimestamp":1787536781,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["OZEM","NVOC","NVOH","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660418064","title":"據報諾和諾德（NVO）啓動低劑量減肥藥試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2660418064","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660418064?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 17:38","pubTimestamp":1787132322,"startTime":"0","endTime":"0","summary":"根据美国政府临床试验数据库最新发布的信息，诺和诺德已于8月12日正式启动一项涵盖450名患者的全新临床研究，旨在评估其热门减肥药索玛鲁肽口服制剂的低剂量疗效。随着减重市场的成熟，诺和诺德希望通过该研究确定在帮助患者维持或达成减重目标的前提下，可使用的最低有效剂量，从而为患者提供更为精准、个性化的口服治疗方案。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/NzFhNTI4MGUwYzI0YmU3ZWQ0MDcxNDc2MTkyOTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NzFhNTI4MGUwYzI0YmU3ZWQ0MDcxNDc2MTkyOTI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303974","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","BK4588","LU0154236417.USD","OZEM","IE00BKVL7J92.USD","PPH","LU1093756325.SGD","NVOH","NVO","LU1093756168.USD","BK4532","BK4007","BK4599","IE00BZ1G4Q59.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660120449","title":"Novo啓動研究，旨在確定Wegovy口服藥的最低有效劑量","url":"https://stock-news.laohu8.com/highlight/detail?id=2660120449","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660120449?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 17:27","pubTimestamp":1787131647,"startTime":"0","endTime":"0","summary":"Novo启动研究，旨在确定Wegovy口服药的最低有效剂量路透伦敦8月19日-据美国政府临床试验数据库显示，丹麦制药公司诺和诺德NOVOb.CO正在一项新的晚期临床研究  中测试其Wegovy口服药的较低剂量，以确定仍能帮助患者减重的最低剂量。其Wegovy口服药在第二季度实现了32.2亿丹麦克朗的销售额，已成为投资者关注的焦点。Wegovy药片目前获批的剂量包括1.5毫克、4毫克、9毫克以及更高剂量的长期用药25毫克。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL4T44G0P1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","IE00BKVL7J92.USD","NVO","PPH","IE00BZ1G4Q59.USD","BK4007","OZEM","LU0154236417.USD","NVOX","BK4532","THNR","BK4599","NVOH","BK4585","BK4588","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660446361","title":"諾和諾德(NVO.US)啓動低劑量Wegovy口服藥臨床研究 瞄準更廣泛減重人群","url":"https://stock-news.laohu8.com/highlight/detail?id=2660446361","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660446361?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 16:50","pubTimestamp":1787129405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["THNR","BK4007","NVO","BK4585","IE00BKVL7J92.USD","BK4599","IE00BZ1G4Q59.USD","NVOH","PPH","NVOX","LU0154236417.USD","BK4588","LU1093756325.SGD","BK4532","LU1093756168.USD","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660448789","title":"大型藥企全力研發無嚴重副作用的減重藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2660448789","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660448789?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 15:34","pubTimestamp":1787124842,"startTime":"0","endTime":"0","summary":"各大制药企业目前正致力于开发新型疗法，在实现相近减重效果的同时，解决当前市场主流药物存在的诸多问题。多数处于研发阶段的主流新药，靶向胰淀素受体。罗氏去年以最高53亿美元的交易获得该药物授权。肯德尔表示，受试者基本未出现严重胃肠道不良反应，这预示用药者将拥有更好的长期用药体验。但她补充，靶向多条通路的复方药物，能够让患者使用更低剂量的减重药物，以此减轻令人不适的副作用。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2026/08/19153458174064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["NVOX","OZEM","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660448604","title":"據媒體消息，諾和諾德(NVO.US)在一項新的肥胖症研究中，開始測試低劑量Wegovy口服藥片。","url":"https://stock-news.laohu8.com/highlight/detail?id=2660448604","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660448604?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 15:31","pubTimestamp":1787124663,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["NVO","IE00BKVL7J92.USD","BK4532","OZEM","LU1093756325.SGD","BK4588","LU0154236417.USD","LU1093756168.USD","PPH","BK4585","BK4007","BK4599","IE00BZ1G4Q59.USD","NVOH","NVOX","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660100064","title":"大型藥企全力研發無嚴重副作用的減重藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2660100064","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660100064?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 15:21","pubTimestamp":1787124088,"startTime":"0","endTime":"0","summary":"蒙扎罗、维格维等减重药物，为研发它们的大型制药企业带来重磅销售业绩。　　尽管这类疗法因改变了数百万人往往备受煎熬的减重过程而广受赞誉，但背后的药企也发现了一个难题：副作用。　　礼来的蒙扎罗、诺和诺德的维格维这类基于肠促胰素的疗法，许多患者反馈出现胃肠道副作用，包括恶心、便秘、腹泻以及呕吐。　　各大制药企业目前正致力于开发新型疗法，在实现相近减重效果的同时，解决当前市场主流药物存在的诸多问题。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-19/doc-ininvshn8362342.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["NVOX","NVOH","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660149850","title":"美股異動｜減肥藥概念股逆勢上揚，禮來漲2.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660149850","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660149850?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 21:54","pubTimestamp":1787061253,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0256863811.USD","IE00BFSS8Q28.SGD","LU1232071149.USD","LU2237443465.HKD","LU2462591350.SGD","LU1917777945.USD","BK4516","LU1093756168.USD","LU2108987350.USD","IE00BK4W5M84.HKD","LU0889565916.HKD","LU1366192091.USD","LU0820561909.HKD","LU1064131342.USD","LU1983299246.USD","LU1280957306.USD","IE0005OL40V9.USD","LU2089984988.USD","LU0417517546.SGD","LU0158827948.USD","LU1979441026.SGD","LU1127390331.HKD","LU2237443382.USD","LU2552382132.HKD","LU0316494557.USD","LU0353189680.USD","LU1069344957.HKD","LU2360106947.USD","LU0198837287.USD","SG9999017495.SGD","LU2471134952.CNY","LU1548497426.USD","LU0823434740.USD","LU1323610961.USD","LU1623119135.USD","LU2552382058.USD","MEDX","IE00BJT1NW94.SGD","RXL","LU2111349929.HKD","LU0471298777.SGD","LU0122379950.USD","LU0882574139.USD","LU0323591593.USD","LU2271345857.HKD","VHT","LU2456880835.USD","LU0456855351.SGD","LU1814569148.SGD","LU2023251221.USD","IE00BJJMRY28.SGD","LU0689472784.USD","LU2089284900.SGD","LU2168564065.EUR","LU0320765059.SGD","LU0210536198.USD","SGXZ31699556.SGD","LU0708995401.HKD","GB00BDT5M118.USD","LU0354030438.USD","LU0345770993.USD","LU0345770308.USD","LU1267930730.SGD","LU1629891620.HKD","LU2028103732.USD","LU2361044865.SGD","LU0943347566.SGD","LU1145028129.USD","LU0820562030.AUD","LU1868836914.USD","SG9999014880.SGD","IE00BKPKM429.USD","IE00BJJMRZ35.SGD","LU2461242641.AUD","LU0354030511.USD","LU1061106388.HKD","LU2213496289.HKD","LU2756315318.SGD","NVOX","LU2087625088.SGD","LU2237443549.SGD","IE00BKVL7J92.USD","LU0096364046.USD","XLV","LU0289739699.SGD","LU1291159041.SGD","MHIP","LU0683600562.USD","IE00B4R5TH58.HKD","IE00BZ1G4Q59.USD","IE00BFTCPJ56.SGD","LU0266013472.USD","LU0238689110.USD","LU1988902786.USD","LU2168564149.EUR","IE0004445239.USD","LU1057294990.SGD","ELIS","SG9999018865.SGD","SG9999014906.USD","LU0823434583.USD","LU0471298694.HKD","LU2063271972.USD","LU1974910355.USD","SG9999015978.USD","LU1712237335.SGD","HRTS","LU0154236417.USD","LU2471134879.HKD","LU1989771016.USD","THNR","LU2746668461.USD","LU0256863902.USD","IE00B1XK9C88.USD","LU0106261372.USD","LU0820561818.USD","LLYX","LU2237443895.HKD","IE00B2B36J28.USD","LU0640476718.USD","LU0882574055.USD","LU0058720904.USD","LU2491050154.USD","LU2750360641.GBP","LU2756315664.SGD","LU1868837136.USD","IE00BKDWB100.SGD","SG9999013999.USD","IE00BJLML261.HKD","LU1093756325.SGD","SG9999014914.USD","LU0061475181.USD","IHE","LU1035775433.USD","LU2168564222.USD","LLII","IE00B7KXQ091.USD","BK4533","IE00BN29S564.USD","LU2361044949.HKD","LU2357305700.SGD","IE00BWXC8680.SGD","LU2491049909.HKD","SG9999001176.SGD","IE00BJJMRX11.SGD","LU2552382215.SGD","LU2265009873.SGD","LLY","SGXZ57979304.SGD","LU2750360997.AUD","LU1868836757.USD","LU2236285917.USD","LU0225283273.USD","LU0823416689.USD","LU2491050071.SGD","PPH","LU0114720955.EUR","LU2168563687.JPY","LU2089283258.USD","LU2462157665.USD","TMED","LU2237443978.SGD","LU1023059063.AUD","LU1720051108.HKD","SG9999015952.SGD","OZEM","SG9999014898.SGD","LU0203201768.USD","LU0097036916.USD","LU0203202063.USD","LU0158827781.USD","IE0009355771.USD","BK4532","LU0094547139.USD","LU2471134796.USD","IE0004445015.USD","LU0964807845.USD","LU1868837300.USD","BK4585","BK4588","GDOC","LU1804176565.USD","LU2023250504.SGD","AGNG","LU2237443622.USD","IE00BK4W5L77.USD","LU2324357040.USD","LU2361045086.USD","NVOH","LU2106854487.HKD","FTXH","LU2168564495.EUR","LU0174119429.USD","LU2211815571.USD","SGXZ51526630.SGD","BK4007","LU0006306889.USD","CANC","LU2417539215.USD","ELIL","IXJ","LU2896262040.SGD","LU0786609619.USD","LU0432979614.USD","JDOC","IE00BFSS7M15.SGD","LU0079474960.USD","IE0002141913.USD","BK4534","LU0109391861.USD","LU0787776722.HKD","IE00B4JS1V06.HKD","LU2237438978.USD","BK4599","LU1868836591.USD","IE00B1BXHZ80.USD","LU0320765992.SGD","IE0001KFT4U8.USD","NVO","LU1720051017.SGD","SG9999001176.USD","LU1551013425.SGD","LU2468319806.SGD","BK4581","SG9999015986.USD","SGXZ81514606.USD","LU0672654240.SGD","IE00B775H168.HKD","LU1551013342.USD","LU0133085943.USD","LU2602419157.SGD","SGXZ99366536.SGD","LLYZ","LU0466842654.USD","LU0109394709.USD","LU2471134523.USD","LU0353189763.USD","LU0385154629.USD","ILDR","SG9999018857.SGD","SG9999015945.SGD","LU2112291526.USD","LU0234572021.USD","LU2023250330.USD","WDNA","LU2264538146.SGD","LU2746668974.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184133485","title":"ETF日報 | 2倍做多AXT ETF升逾35%；2倍做多Cerebras ETF升逾30%；三倍做多半導體ETF漲近5%；半導體槓桿領升","url":"https://stock-news.laohu8.com/highlight/detail?id=1184133485","media":"ETF追踪","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184133485?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 04:06","pubTimestamp":1786997187,"startTime":"0","endTime":"0","summary":"美股ETF涨幅Top5T-REX 2X LONG AXTI DAILY TARGET ETF上涨35.49%。Leverage Shares 2X Long AXTI Daily ETF上涨35.27%。Tradr 2X Long AXTI Daily ETF上涨35.05%。Corgi AXTI 2x Daily ETF上涨34.88%。该产品两倍做多AI芯片公司Cerebras Systems，底层公司股价走强，杠杆机制放大当日涨幅。美股ETF跌幅Top5Tradr 2X ShortCBRS Daily ETF下跌29.76%。2倍做空SNDK ETF-Tradr下跌17.65%。2倍做多GEMI ETF-Leverage Shares下跌16.50%。2倍做多RDDT ETF-GraniteShares下跌15.03%。行业指数ETF涨幅Top 5Direxion Daily Semiconductor Bull 3X Shares上涨4.54%。债券ETF涨幅Top 5First Trust Emerging Markets Local Currency Bond ETF上涨0","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLDM","512480","BK4007","GLD","MQQQ","OILU","TEKX","GEMG","IEO","ASHR","SMHU","YSPY","IAUI","FGDL","BK4588","SKF","LU2290526834.HKD","CNAV","HIBL","02822","EIS","DGP","OSSL","82822","DMAX","LU1861220033.SGD","AXTX","SSO","SIVR","EDC","SMAX","CBRX","PSI","PXJ","SPYQ","USL","AXTI","TEUP","FWD","SDS","SPDN","LU2543165471.USD","NRGZ","GLDY","AGQ","ONTX","SHNY","IVV","SOXX","SNDK","AAAU","EEMO","IE0031619046.USD","CBRZ","DBC","OILK","GUSH","ASHS","CNXT","SPYH","SPUU","CWEB","LITC","ICVT","BNO","LU2360107168.USD","COWZ","NVOX","SMHX","CHAU","MMAX","RILY","BKLN","SOXQ","RDTL","EBND.AU","BK4570","XPP","XSD","SIMX","DRIP","MVV","82823","BK4550","DISK","SPXL","AXTL","SOCL","CHPY","FXP","RGTC","OILT","82843","BK4603","SMH","BK4077","LUMA","ALA","DZZ","IE00B66KJ199.SGD","DBE","MIDU","SPYM","LU0274383776.USD","XITK","SPXS","COZX","AXTC","EEMA","SCHM","SPXU","USD","GLL","NUGT","COWG","BK4585","CBRS","RDYY","SPXT","BK4547","LU2089985449.USD","CWC","RDDT","02843","SNDQ","LAZR","BK4127","BGLD","EQL","OPTZ","USE","LU1861215975.USD","VOO","SGOL","YANG","FAZ","LU0054578231.USD","UMDD","SOXL","UGA","ZSL","OUNZ","SSG","OIH","NBIC","PTF","DUG","KGLD","LU0963586101.USD","SH","NVTC","NBDS","USO","FLCH","DRV","FDN","DXD","BK4535","SAA","SCHA","SOXY","02823","XES","SLV","IAUM","EWY","SOXS","YGLD","SNXX","IGLD","XW","ETNG","DBO","BK4141","DRNZ","UCO","FSMD","BK4170","WTIU","VRC","IXC","XLEX","USOI","AXTU","ERX","FTXN","DULL","UMAL","YXI","QQQG","SPY","BAR","UMAC","DGZ","IE00B7SZL793.SGD","VGT","NVOH","UPRO","FCUS","PXE","FTXL","FCVT","159582","LU2063271972.USD","KWEB","EWK","SCO","TMSL","SNDG","TECY","LU2931357623.SGD","YINN","BK4157","DRLL","CHPS","UGL","IE00B19Z4B17.USD","SPYU","FNGZ","BK4147","DIG","EBND","FEMB","EDZ","SNDU","SNDC","VDE","IAU","USG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660648687","title":"步長製藥：控股子公司藥品臨床試驗申請獲受理，研發投入約3175.45萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660648687","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660648687?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 17:16","pubTimestamp":1786958196,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["TBXU","NVOH","NVOX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}